Nanocellulose-based Synergistic Systems for Advanced Healthcare

This inventive concept integrates nanocellulose-derived hydrogels with distinct technologies, such as AI, IoT, blockchain, and novel materials, to create powerful systems for personalized diabetes management, real-time protein stability monitoring, secure pharmaceutical supply chain management, customized oral drug delivery, and optimized protein loading and sustained release.

The original patent, 'Nanocellulose as an embedding matrix and applications thereof,' provided a versatile nanocellulose-derived hydrogel drug delivery system for oral dosing pharmaceuticals. However, it had limitations in terms of scalability, monitoring, and security. The new inventive concept addresses these limitations by synergistically combining nanocellulose with other technologies to create more advanced and efficient systems.

The new claims encompass five distinct systems: (1) a personalized diabetes management system integrating nanocellulose-based oral insulin delivery with an AI-powered health monitoring platform, (2) an IoT-enabled real-time protein stability monitoring method for nanocellulose-derived hydrogels, (3) a blockchain-based secure data management system for tracking nanocellulose-based pharmaceuticals, (4) a novel nanocellulose-polymer composite material for 3D printing customized oral drug delivery devices, and (5) a synergistic combination of nanocellulose-based hydrogels with graphene oxide for enhanced protein loading and sustained release. These systems leverage the benefits of nanocellulose while addressing the limitations of the original patent.

The new claims introduce novel synergistic combinations of nanocellulose with distinct technologies, providing a non-obvious and innovative approach to advanced healthcare systems. The integration of AI, IoT, blockchain, and novel materials with nanocellulose-derived hydrogels creates a new paradigm for efficient, secure, and personalized healthcare solutions.

Alternative embodiments of the inventive concept could include the integration of nanocellulose with other emerging technologies, such as quantum computing or synthetic biology, to further enhance the capabilities of the systems. Additionally, variations of the systems could be developed for specific therapeutic applications or disease management.

The inventive concept has significant commercial potential in the healthcare industry, particularly in the areas of diabetes management, pharmaceutical development, and personalized medicine. The target market includes pharmaceutical companies, healthcare providers, and medical device manufacturers seeking to develop and integrate advanced healthcare systems.